AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…